Mayinglong Hemorrhoidal PETROLATUM, ZINC OXIDE 779.9 mg/g; 76 mg/g Ointment
by Mayinglong Pharmaceutical Group Co., Ltd. · 1 TUBE in 1 BOX (68511-998-01) / 10 g in 1 TUBE
NDC 68511-0998-01
🏷️ FDA NDC (as labeled)
68511-998-01
billing pads the product segment with a zero
This package
Contains10 g in 1 tube
Pack sizes2 compare ↓
Also comes in:
10 g 68511-0998-02
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
68511-998-01
Product NDC
68511-998
11-digit billing NDC
68511099801
RxCUI
2396041
UNII
4T6H12BN9U, SOI2LOH54Z
UPC
0860001004960
Application #
M015
SPL Set ID
b14192ea-1bf7-da6a-e053-2a95a90a5b5e
Established class (EPC)
Copper Absorption Inhibitor
Physiologic effect
Decreased Copper Ion Absorption
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2018-08-01
Route
TOPICAL
Dosage form
OINTMENT
Substance
PETROLATUM; ZINC OXIDE
Why two NDCs?
The FDA registers this code as 68511-998-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 68511-0998-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerMayinglong Pharmaceutical Group Co., Ltd.
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code68511
First marketedAug 2018
Product typeHuman Otc Drug
Portfolio2 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
🧪 What is this product?
This is an over-the-counter topical ointment marketed under FDA's OTC monograph rules for hemorrhoidal products. Petrolatum and zinc oxide are the active ingredients, commonly used together in such preparations to help soothe and protect irritated skin. Petrolatum functions as an emollient and barrier, while zinc oxide is typically included for its skin-protective and mild astringent properties. The product is applied directly to the affected area.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about PETROLATUM, ZINC OXIDE?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
10 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Ma Ying Long Musk Hemorrhoids 779.9 mg/g; 76 mg/g 68511-0997-02 | Mayinglong | 1 tube | — | — | FDA listed | — |
| Mayinglong Hemorrhoidal 779.9 mg/g; 76 mg/gthis 68511-0998-01 | Mayinglong | 1 tube | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2018
On the market since
Aug 2018
📍
2026
Currently FDA-listed
8 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for PETROLATUM, ZINC OXIDE — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 40%
Female · 60%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 68511-0998-01 You're viewing this | 1 TUBE in 1 BOX (68511-998-01) / 10 g in 1 TUBE | 2018-08-01 | Active |
| 68511-0998-02 | 1 TUBE in 1 BOX (68511-998-02) / 10 g in 1 TUBE | 2018-08-01 | Active |
Pack size FAQ
What quantity is in NDC 68511-0998-01?
NDC 68511-0998-01 is listed by the FDA — 1 tube in 1 box / 10 g in 1 tube.
What NDC number is used to bill for this package of Mayinglong Hemorrhoidal PETROLATUM, ZINC OXIDE 779.9 mg/g; 76 mg/g Ointment?
Bill NDC 68511-0998-01 — the 11-digit billing format is 68511099801. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 68511-998-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 68511-0998-01, written without dashes as 68511099801. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 68511-0998-01, the first segment (68511) is the labeler code FDA assigned to Mayinglong Pharmaceutical Group Co., Ltd.; the middle segment (0998) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Mayinglong Pharmaceutical Group Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tube (68511-0998-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Mayinglong Pharmaceutical Group Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses For the temporary relieve of local itching and discomfort associated with hemorrhoids. Temporarily forms a protective coating over inflamed tissues to help prevent drying of tissues. Temporarily protects irritated areas.
Temporarily relieves burning. Provides temporary relief from skin irritations. Temporarily provides a coating for relief of anorectal discomforts.
Temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful. Temporarily protects inflamed perianal skin. Temporarily relieves the symptoms of perianal skin irritation.
⏱️ Dosage and Administration ▾
Directions Adults: When practical, cleanse the affected area with mild soap and warm water, rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of the ointment. Apply to the affected area up to 2 times daily or after each bowel movement.
Apply liberally to the affected area. Attach applicator to tube. Lubricate applicator well with ointment, then gently insert applicator into the rectum.
FOR INTRARECTAL USE: Children under 12 years of age: consult a doctor.
⚠️ Warnings ▾
Warnings For external use and/or intrarectal use only Do not use If allergic to any of the ingredients When using this product Do not exceed the recommended daily dosage unless as directed by a doctor. Do not use the product with an applicator if the introduction of the applicator into the rectum causes additional pain. Consult a doctor promptly.
Stop use and ask a doctor if Bleeding occurs Condition worsens or does not improve within 7 days Do not use during pregnancy or when breast feeding. Consult a health professional before use. Keep out of reach of children to avoid accidental poisoning.
If swallowed, get medical help or contact a Poison Control Center right away Do not use otherwise than as directed.
🧪 Active Ingredient ▾
Active ingredients Petrolatum 77.99% Calamine 7.6% Purpose Protectant Astringent
🧪 Inactive Ingredients ▾
Inactive ingredients Amber, Artificial bezoar (Bos Taurus Bile, Cholic Acid,D eoxycholic Acid, Taurine, Bilirubin, Cholesterol), Artificial musk (Muscone), Borax, Borneol, Dimethyl sulfoxide, Lanolin, Pear
🎯 Purpose ▾
Purpose Protectant Astringent
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.